查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411358

貧血治療藥物市場：按藥物、類型、給藥途徑和最終用戶分類 - 全球預測 2024-2030

Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年貧血治療藥物市場規模為195.5億美元，預計2024年將達212.4億美元，2030年將達399.9億美元，複合年成長率為10.76%。

全球貧血藥物市場

主要市場統計
基準年[2023] 195.5億美元
預測年份 [2024] 212.4億美元
預測年份 [2030] 399.9億美元
複合年成長率（%） 10.76%
貧血治療藥物市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估貧血治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對貧血治療藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-貧血治療藥物市場的市場規模與預測是多少？

2-貧血治療藥物市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-貧血治療藥物市場的技術趨勢和法律規範是什麼？

4-貧血治療藥物市場主要供應商的市場佔有率是多少？

5-進入貧血藥物市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和貧血盛行率增加
      • 生活方式的改變和加工食品的過度消費
      • 人口變化和階段婦女人數增加
    • 抑制因素
      • 與過量攝取貧血治療藥物相關的副作用
    • 機會
      • 政府核准開發新的和創新的貧血治療方法
      • 旨在生產貧血治療藥物的研發活動
    • 任務
      • 貧血藥物因安全問題被撤回
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 貧血治療藥物（依市場藥品分類）

  • 阿糖酶注射液
  • 羰基鐵
  • 氰鈷胺素
  • 達布·波廷·阿爾法
  • Eculizumab
  • 紅血球生成素BETA-甲氧基聚乙二醇
  • 富馬酸亞鐵
  • 聚葡萄糖鐵
  • 鐵補充品

第7章貧血治療藥物市場：依類型

  • 再生障礙性貧血
  • 慢性腎臟病病貧血
  • 溶血性貧血
  • 缺鐵性貧血
  • 惡性貧血
  • 鐮狀細胞性貧血
  • 維生素缺乏性貧血

第8章貧血治療藥物市場：依給藥途徑分類

  • 可注射的
  • 口服

第9章貧血治療藥物市場：依最終用戶分類

  • 醫院
  • 自我管理

第10章北美及南美洲貧血治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區貧血治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲貧血治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • AbbVie Inc. by Allergan PLC
    • ADZO Lifesciences Pvt Ltd.
    • Akebia Therapeutics, Inc.
    • Alembic Pharmaceuticals Limited
    • Alkem Laboratories Ltd.
    • Aqunova Pharma Private Limited
    • Astraea Life Sciences Pvt Ltd
    • Bluebird Bio, Inc.
    • Cadila Pharmaceuticals Ltd.
    • Corona Remedies Pvt Ltd.
    • Covis Pharma GmbH
    • Dr. Reddy's Laboratories
    • Emcure Pharmaceuticals
    • Glenmark Pharmaceuticals Ltd.
    • GSK PLC
    • Gujarat Terce Laboratories Ltd.
    • Lupin Ltd.
    • Pfizer Inc.
    • Pharmacosmos A/S
    • Pieris Pharmaceuticals, Inc.
    • Sanofi SA
    • Solitaire Pharmacia Pvt. Ltd.
    • Sun Pharmaceutical Industries Limited
    • Takeda Pharmaceutical Company Limited
    • Triton Healthcare Pvt Ltd.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-DD0700E81E07

[197 Pages Report] The Anemia Drugs Market size was estimated at USD 19.55 billion in 2023 and expected to reach USD 21.24 billion in 2024, at a CAGR 10.76% to reach USD 39.99 billion by 2030.

Global Anemia Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 19.55 billion
Estimated Year [2024] USD 21.24 billion
Forecast Year [2030] USD 39.99 billion
CAGR (%) 10.76%
Anemia Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anemia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anemia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anemia Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc. by Allergan PLC, ADZO Lifesciences Pvt Ltd., Akebia Therapeutics, Inc., Alembic Pharmaceuticals Limited, Alkem Laboratories Ltd., Aqunova Pharma Private Limited, Astraea Life Sciences Pvt Ltd, Bluebird Bio, Inc., Cadila Pharmaceuticals Ltd., Corona Remedies Pvt Ltd., Covis Pharma GmbH, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals Ltd., GSK PLC, Gujarat Terce Laboratories Ltd., Lupin Ltd., Pfizer Inc., Pharmacosmos A/S, Pieris Pharmaceuticals, Inc., Sanofi S.A., Solitaire Pharmacia Pvt. Ltd., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, and Triton Healthcare Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Anemia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug
    • Alglucerase Injection
    • Carbonyl Iron
    • Cyanocobalamin
    • Darbepoetin Alfa
    • Eculizumab
    • Epoetin Beta-methoxy Polyethylene Glycol
    • Ferrous FumarateIron
    • Iron Dextran
    • Iron Supplements
  • Type
    • Aplastic Anemia
    • Chronic Kidney Disease Anemia
    • Hemolytic Anemia
    • Iron Deficiency Anemia
    • Pernicious Anemia
    • Sickle Cell Anemia
    • Vitamin Deficiency Anemia
  • Route of Administration
    • Injectable
    • Oral
  • End-Users
    • Hospital
    • Self-Administered
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anemia Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anemia Drugs Market?

3. What are the technology trends and regulatory frameworks in the Anemia Drugs Market?

4. What is the market share of the leading vendors in the Anemia Drugs Market?

5. Which modes and strategic moves are suitable for entering the Anemia Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anemia Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases and anemia
      • 5.1.1.2. Changing lifestyles and over-consumption of packaged and processed foods
      • 5.1.1.3. Shifting demographics and growing number of women in reproductive stages
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with overconsumption of anemia drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Government approvals for the development of new and innovative anemia drugs
      • 5.1.3.2. Research and development activities for the production of anemia drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Recall of anemia drugs over safety concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anemia Drugs Market, by Drug

  • 6.1. Introduction
  • 6.2. Alglucerase Injection
  • 6.3. Carbonyl Iron
  • 6.4. Cyanocobalamin
  • 6.5. Darbepoetin Alfa
  • 6.6. Eculizumab
  • 6.7. Epoetin Beta-methoxy Polyethylene Glycol
  • 6.8. Ferrous FumarateIron
  • 6.9. Iron Dextran
  • 6.10. Iron Supplements

7. Anemia Drugs Market, by Type

  • 7.1. Introduction
  • 7.2. Aplastic Anemia
  • 7.3. Chronic Kidney Disease Anemia
  • 7.4. Hemolytic Anemia
  • 7.5. Iron Deficiency Anemia
  • 7.6. Pernicious Anemia
  • 7.7. Sickle Cell Anemia
  • 7.8. Vitamin Deficiency Anemia

8. Anemia Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral

9. Anemia Drugs Market, by End-Users

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Self-Administered

10. Americas Anemia Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anemia Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anemia Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc. by Allergan PLC
    • 14.1.2. ADZO Lifesciences Pvt Ltd.
    • 14.1.3. Akebia Therapeutics, Inc.
    • 14.1.4. Alembic Pharmaceuticals Limited
    • 14.1.5. Alkem Laboratories Ltd.
    • 14.1.6. Aqunova Pharma Private Limited
    • 14.1.7. Astraea Life Sciences Pvt Ltd
    • 14.1.8. Bluebird Bio, Inc.
    • 14.1.9. Cadila Pharmaceuticals Ltd.
    • 14.1.10. Corona Remedies Pvt Ltd.
    • 14.1.11. Covis Pharma GmbH
    • 14.1.12. Dr. Reddy's Laboratories
    • 14.1.13. Emcure Pharmaceuticals
    • 14.1.14. Glenmark Pharmaceuticals Ltd.
    • 14.1.15. GSK PLC
    • 14.1.16. Gujarat Terce Laboratories Ltd.
    • 14.1.17. Lupin Ltd.
    • 14.1.18. Pfizer Inc.
    • 14.1.19. Pharmacosmos A/S
    • 14.1.20. Pieris Pharmaceuticals, Inc.
    • 14.1.21. Sanofi S.A.
    • 14.1.22. Solitaire Pharmacia Pvt. Ltd.
    • 14.1.23. Sun Pharmaceutical Industries Limited
    • 14.1.24. Takeda Pharmaceutical Company Limited
    • 14.1.25. Triton Healthcare Pvt Ltd.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANEMIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANEMIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANEMIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANEMIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANEMIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANEMIA DRUGS MARKET DYNAMICS
  • FIGURE 7. ANEMIA DRUGS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 8. ANEMIA DRUGS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANEMIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANEMIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ANEMIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ANEMIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANEMIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANEMIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANEMIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 6. ANEMIA DRUGS MARKET SIZE, BY ALGLUCERASE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANEMIA DRUGS MARKET SIZE, BY CARBONYL IRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANEMIA DRUGS MARKET SIZE, BY CYANOCOBALAMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANEMIA DRUGS MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANEMIA DRUGS MARKET SIZE, BY ECULIZUMAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANEMIA DRUGS MARKET SIZE, BY EPOETIN BETA-METHOXY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANEMIA DRUGS MARKET SIZE, BY FERROUS FUMARATEIRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANEMIA DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ANEMIA DRUGS MARKET SIZE, BY APLASTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANEMIA DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANEMIA DRUGS MARKET SIZE, BY HEMOLYTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANEMIA DRUGS MARKET SIZE, BY IRON DEFICIENCY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANEMIA DRUGS MARKET SIZE, BY PERNICIOUS ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANEMIA DRUGS MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANEMIA DRUGS MARKET SIZE, BY VITAMIN DEFICIENCY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. ANEMIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ANEMIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. ANEMIA DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ANEMIA DRUGS MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 197. ANEMIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 198. ANEMIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 199. ANEMIA DRUGS MARKET LICENSE & PRICING